Joshua Rottner has a business and corporate practice with an emphasis on representing high growth technology and life sciences companies throughout their lifecycle, from entity formation, through debt and equity financings, to liquidity events such as merger and acquisition transactions and public offerings. He also advises public companies in merger and acquisition transactions, public offerings and SEC periodic reporting and compliance.
Download full bio